The GLP-1 analogue liraglutide decreases the pro-inflammatory status of the heart in diabetes

被引：0
|
作者：
Emmens, R. W. [1 ]
Baylan, U. [1 ]
Naaijkens, B. [1 ]
Schalkwijk, C. G. [2 ]
Niessen, H. W. M. [1 ]
Krijnen, P. A. J. [1 ]
Simsek, S. [3 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Maastricht Univ, CARIM, Dept Internal Med, Maastricht, Netherlands
[3] Med Ctr Alkmaar, Alkmaar, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [41] Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
    Russell-Jones, David
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 297 (1-2) : 137 - 140
  • [42] Liraglutide, a human GLP-1 analogue, lowers HbA1c independent of weight loss
    Schmidt, W. E.
    Gough, S.
    Madsbad, S.
    Zinman, B.
    Falahati, A.
    Toft, A. D.
    Sesti, G.
    DIABETOLOGIA, 2009, 52 : S289 - S289
  • [43] The long-acting GLP-1 analogue liraglutide regulates zinc transporter mRNA in β cells
    Magnusson, N.
    Knudsen, L. Bjerre
    Wogensen, L.
    Brock, B.
    Schmitz, O.
    Egefjord, L.
    Jeppesen, J. B.
    Rungby, J.
    DIABETOLOGIA, 2007, 50 : S65 - S65
  • [44] Influence of hepatic impairment on pharmacokinetics of the long-acting human GLP-1 analogue liraglutide
    Flint, Anne
    Nazzal, Khalil
    Jagielski, Pawel
    Segel, Stine
    Zdravkovic, Milan
    DIABETES, 2007, 56 : A145 - A145
  • [45] Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline
    Schmitz, O.
    Russell-Jones, D.
    Shaw, J.
    Brandle, M.
    Matthews, D.
    Frid, A.
    Zdravkovic, M.
    Garber, A.
    Zinman, B.
    DIABETOLOGIA, 2008, 51 : S354 - S355
  • [46] Pharmacokinetics of the long-acting human GLP-1 analogue liraglutide in subjects with renal impairment
    Jacobsen, L. V.
    Hindsberger, C.
    Robson, R.
    Zdravkovic, M.
    DIABETOLOGIA, 2007, 50 : S352 - S352
  • [47] Beneficial effects of Liraglutide, GLP-1 analogue, on cardiovascular risk factors in the type 2 diabetic
    Halimi, S.
    Lalanne, G.
    Ravaut, J. F.
    Reigneau, O.
    Dejager, S.
    DIABETES & METABOLISM, 2007, 33 : S18 - S18
  • [48] GLP-1 receptor agonists and heart failure in diabetes
    Scheen, Andre J.
    DIABETES & METABOLISM, 2017, 43 : 2S13 - 2S19
  • [49] Pharmacokinetics of the long-acting human GLP-1 analogue liraglutide in subjects with renal impairment
    Jacobsen, Lisbeth V.
    Hindsberger, Charlotte
    Robson, Richard
    Zdravkovic, Milan
    DIABETES, 2007, 56 : A137 - A137
  • [50] The long-acting GLP-1 analogue liraglutide regulates zinc transporter mRNA in β-cells
    Rungby, Jorgen
    Wogensen, Lise
    Brock, Birgitte
    Schmitz, Ole
    Jeppesen, Johanne B.
    Knudsen, Lotte Bjerre
    Smidt, Kamille
    DIABETES, 2007, 56 : A437 - A437
12345